Recently, Galderma Group AG announced its financial results for the first half of 2025, reporting net sales of $2.448 billion, a 12.2% increase year-on-year on a constant currency basis, marking a new record for the period. The second quarter saw particularly strong momentum, with sales growing 15.8% year-on-year.
The company attributed its performance to volume-driven growth, an enhanced product mix, and consistent execution across its global footprint. All three of Galderma’s core businesses—Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology—delivered solid results, with notable contributions from the continued ramp-up of Nemluvio® and the launch of Relfydess™, its next-generation injectable filler.
In half year of 2025, the Injectable Aesthetics segment achieved 9.8% growth with $1.240 billion. Dermatological Skincare generated net sales of $719 million, reflecting 7.7% year-on-year growth, supported by flagship brands Cetaphil® and Alastin®, and strong performance in both e-commerce and international markets.
Growth was balanced across geographies. In International markets, sales rose 12.1% with $1.409 billion, led by standout performances in China, India, Canada, Brazil, and across Europe. The U.S. market also grew by 12.3% with $1.039 billion, supported by strong uptake of Nemluvio, renewed growth in Injectable Aesthetics, and sustained demand for Dermatological Skincare products.
Commenting on the results, Flemming Ørnskov, M.D., MPH, Chief Executive Officer of Galderma, said:
“Galderma continues to deliver strong, broad-based performance across all product categories and geographies. The successful commercial rollouts of Nemluvio and Relfydess demonstrate our innovation leadership in dermatology. With sustained momentum, we are pleased to raise our full-year guidance and remain confident in our ability to drive profitable growth and value creation.”
Looking ahead, the company upgraded its full-year 2025 revenue growth outlook to 12–14%, while reaffirming its Core EBITDA margin guidance of approximately 23%.
